1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. JUPITER LIFE LINE HOSPITALS LTD.
Jupiter Life Line Hospitals Ltd.
NSE: JLHL | BSE: 543980

Jupiter Life Line Live Share Price Today, Share Analysis and Chart

aboutJupiter Life Line Hospitals Ltd. (JLHL) is a multi-specialty tertiary and quaternary healthcare provider primarily operating in the Mumbai Metropolitan Area (MMA) and western India. The company follows an asset-owned model, where it typically owns th... Read More
Occupancy RateARPOB (Rev per Bed)
Ask AI about Jupiter Life Line
289.75-0.15(-0.05%)
106.6K
NSE+BSE Volume

NSE 17 Nov, 2026 3:31 PM

Portfolio

Alert

My Notes

Jupiter Life Line Stock Price Ranges

Day Price Range

-0.0% 1 Day return
289.8 (LTP)
283.2294.8
LowHigh

Week Price Range

-0.8% 1 Week return
289.8 (LTP)
280.2296
LowHigh

Month Price Range

17.3% 1 Month return
289.8 (LTP)
233.4296
LowHigh

52 Week Price Range

-1.0% 1 Year return
289.8 (LTP)
233.4340
LowHigh

Jupiter Life Line Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

EPS forecast

CURRENT EPS
5.9
AVG. ESTIMATE
6
LOW ESTIMATE
5.3
HIGH ESTIMATE
6.4
CURRENT EPS
AVG. ESTIMATE

Consensus Recommendation

6 ANALYST Recommendations
STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Jupiter Life Line Technical Analysis

Jupiter Life Line EMA & SMA

Bullish+8
Bullish8
Bearish0
5 Day288.1
10 Day284.0
12 Day282.1
20 Day276.3
26 Day274.1
50 Day273.6
100 Day276.3
200 Day277.4

Jupiter Life Line Delivery And Volume

Daily Avg. Delivery Volume %
17 Nov, 202655.0%
Week49.8%
Month56.6%
PositiveNeutralNegative

Jupiter Life Line Resistance and Support

289.22
Pivot
First Resistance295.3
Second Resistance300.8
Third Resistance306.9
First Support283.7
Second Support277.6
Third Support272.1
Day RSI66.2
Day MACD8
Day MFI80.8
Day MACD Signal Line5.6

Jupiter Life Line Beta

1 Month0.6
1 Year0.3
3 Month0.5
3 Year0.4

Jupiter Life Line Price Change Analysis

↑17.3%
Over 1 Month
LowHigh
233.4296
↓-8.2%
Over 3 Months
LowHigh
233.4324
↑9.2%
Over 6 Months
LowHigh
233.4340
↓-1.1%
Over 1 Year
LowHigh
233.4340

Jupiter Life Line Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Ajay Pratap ThakkerPromoter67,989,14520.7 %
Goldman Sachs Funds - Goldman Sachs India Equity PFii9,029,2802.8 %
Mihir Wire Industries LlpPublic7,050,0002.2 %
Sbi Healthcare Opportunities FundDii24,353,0827.4 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Jupiter Life Line Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
MITUL NITIN THAKKERBlockSell15 Jul 20261483.50600,000BSE
ARVIND RAO RAO KAMINIBlockSell15 Jul 20261483.50337,000BSE
HDFC MUTUAL FUNDBlockPurchase15 Jul 20261483.50600,000BSE
HDFC MUTUAL FUNDBlockPurchase15 Jul 20261483.50337,000BSE
ARVIND RAO RAO KAMINIBulkSell15 Jul 20261483.50337,000BSE
MITUL NITIN THAKKERBulkSell15 Jul 20261483.50600,000BSE
HDFC MUTUAL FUNDBulkPurchase15 Jul 20261483.50937,000BSE
SBI MUTUAL FUNDBulkSell13 Nov 20251497.802,313,613NSE
SBI MUTUAL FUNDBulkPurchase13 Nov 20251497.802,313,615NSE
BRINDHA RAGHAVANBlockSell29 Aug 20241310100,000NSE

Jupiter Life Line Corporate Actions

Jupiter Life Line Dividend history and yield

Jupiter Life Line dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Jupiter Life Line dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
122 May 2026
1INTERIM22 May 2026Equity Share
204 Jul 2025
1FINAL04 Jul 2025Equity Share
302 Aug 2024
1FINAL02 Aug 2024Equity Share

Jupiter Life Line Board Meetings

Jupiter Life Line past and upcoming board meetings.

#Ex-Date
PurposeNotes
123 Oct 2026
Quarterly Results-
231 Jul 2026
Quarterly Results-
315 May 2026
Quarterly Results, Int. Dividend & Stock Split-
430 Jan 2026
Quarterly Results-
507 Nov 2025
Quarterly Results-

Jupiter Life Line Stock Split

Jupiter Life Line stock split details, including announcement, record, and ex-split dates, along with the split ratios

#Ex-Date
Old FVNew FVRecord Date
124 Jul 2026
10224 Jul 2026

Jupiter Life Line Research Reports

Jupiter Life Line research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
118 May 2026Prabhudas Lilladhar16001328.9Buy20.4%-78.2%pdf
218 May 2026Anand Rathi15601328.9Buy17.39%-78.2%pdf
309 Mar 2026Prabhudas Lilladhar16001264.9Buy26.49%-77.09%pdf
402 Feb 2026Prabhudas Lilladhar16001257.5Buy27.24%-76.96%pdf
510 Nov 2025Prabhudas Lilladhar
Target
18001506Buy19.52%-80.76%pdf

Jupiter Life Line Corporate Filings

Jupiter Life Line BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
12 Nov 2026
Jupiter Life Line Hospitals Ltd - 543980 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)
Addition of approximately 40-50 beds to the existing Thane Hospital.
PDF
09 Nov 2026
Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.
PDF
29 Oct 2026
Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q2 FY27 Earnings Conference Call - Transcript
PDF
26 Oct 2026
Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Link of Analyst/ Investor Conference Call for Q2 & H1 FY27
PDF
26 Oct 2026
Jupiter Life Line Hospitals Results Earnings Call for Q2FY27
Conference Call with Jupiter Life Line Hospitals Management and Analysts on Q2FY27 Performance and Outlook. Listen to the full earnings transcript.
PDF

Jupiter Life Line Documents

Jupiter Life Line Earnings Call

Jupiter Life Line earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
29 Oct 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26 Oct 2026Jupiter Life Line Hospitals Results Earnings Call for Q2FY27
07 Aug 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
03 Aug 2026Jupiter Life Line Hospitals Results Earnings Call for Q1FY27
21 May 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Jupiter Life Line Annual Reports

Jupiter Life Line financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024

Jupiter Life Line Investor Presentations

Jupiter Life Line investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
23 Oct 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Investor Presentation
31 Jul 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Investor Presentation
15 May 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Investor Presentation
31 Jan 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Investor Presentation
30 Jan 2026Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Investor Presentation

Jupiter Life Line - Company Profile

Jupiter Life Line Management Structure

Jupiter Life Line management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
ANKIT AJAY THAKKERExecutive Director,Joint Managing Director,Chief Executive Officer-Mar 26
Mr. Harshad PuraniPresident(Administration),Head(CSR)-Mar 26
Dr. Shilpa TatakeChief Executive Officer(Hospital)-Mar 26
Mr. Anand ApteChief Business Officer,Investor Relations Officer-Mar 26
Dr. Rajendra PatankarChief Executive Officer(Hospital)-Mar 26
Mr. Neelesh ShindeChief Technical Officer,Head(Projects)-Mar 26
Mrs. Manisha ShahGroup Chief Human Resources Officer-Mar 26
Mr. Sumit GodaChief Commercial Officer-Mar 26
Suma UpparattiCompany Secretary,Compliance Officer-Mar 26
Mr. Sivasis Salilkumar SenChief Financial Officer-Mar 26

Jupiter Life Line Board of Directors

Jupiter Life Line Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
AJAY PRATAP THAKKERChairman & Managing Director388.8Mar 25
ANKIT AJAY THAKKERManaging Director & Chief Executive Officer259.2Mar 25
Satish UtekarIndependent Director1.5Mar 25
DARSHAN HIRALAL VORAIndependent Director1.15Mar 25
Urmi PopatIndependent Director1Mar 25
JASMIN A PATELIndependent Director0.55Mar 25
Amar ManjrekarIndependent Director0.45Mar 25
Bhaskar Prataprai ShahNon Executive Director-Mar 25
Vadapatra Sayee RaghavanNon Executive Director-Mar 25
Suma UpparattiCompany Sec. & Compli. Officer-Mar 25

About the company - Business Profile

Jupiter Life Line Hospitals Ltd. (JLHL) is a multi-specialty tertiary and quaternary healthcare provider primarily operating in the Mumbai Metropolitan Area (MMA) and western India. The company follows an asset-owned model, where it typically owns the underlying land and hospital infrastructure. JLHL operates under the "Jupiter" brand, providing specialized medical services across various specialties, including cardiology, oncology, neurosciences, and orthopaedics.

Key Points

Key Facts

  • Founded Year: 2002
  • Headquarters: Thane, Maharashtra, India
  • Stock Listing: Listed on BSE (Code: 543980) and NSE (Symbol: JLHL)
  • Market Capitalization: ₹10,447.62 crore (as of March 31, 2025)

Operations and Resources

  • Existing Facilities: Operates three major hospitals located in Thane, Pune, and Indore.
  • Bed Capacity: As of December 31, 2025, the total existing operational bed capacity was 1,048 beds.
  • Expansion: A new 500-bed facility in Dombivli was operationalized ahead of schedule, with the OPD starting in early February 2026 and full clinical operations on February 18, 2026. Phase I of this project involved 300 fit-out beds and 200 operational beds.
  • Future Pipeline: Projects are underway in Pune South (Bibwewadi) (500 beds, expected CY28) and Mira-Bhayandar (300 beds, expected CY29), aiming for a total capacity of approximately 2,500 beds.

Business Model and Performance

  • Revenue Model: JLHL focuses on a high-margin "Patient First" model with a significant portion of revenue derived from self-pay and insured patients rather than government schemes.
  • Geographical Presence: Concentrated in the high-growth markets of Maharashtra and Madhya Pradesh.

Revenue and Financial Highlights (FY 2024-25)

  • Revenue from Operations: ₹1,245.40 crore (Annual FY25)
  • EBITDA: ₹296.60 crore (Margin: 23.5%)
  • Profit After Tax (PAT): ₹193.50 crore (Margin: 15.3%)
  • 9MFY26 Performance: For the nine months ended December 31, 2025, revenue from operations reached ₹1,063.8 crore, a 15.3% YoY increase. EBITDA for the same period was ₹254.0 crore.

Operational Metrics (9MFY26)

  • ARPOB (Average Revenue Per Occupied Bed): ₹66,800 (vs ₹59,000 in 9MFY25)
  • Average Occupancy Rate: 61.9% (reflecting expanded capacity)
  • ALOS (Average Length of Stay): 3.85 days
  • Payor Mix: Insurance (55.7%), Self-Pay (43.2%), and Government Schemes (1.1%).

Key Products and Technology

  • Diagnostic Advancement: Utilization of mammography with tomosynthesis for early breast cancer detection.
  • Therapeutic Systems: Radiation therapies including 3DCRT, IMRT, and SBRT delivered through EBRT or Internal Radiation Therapy.
  • Automation: Automated systems for scheduling and calibration across connected medical analyzers.

Sustainability and Strategic Initiatives

  • Clinical Talent: Focus on a "doctor-led" model to ensure high-quality quaternary care.
  • Strategic Growth: Aggressive expansion in the western region of India, targeting high-density residential hubs for new greenfield hospitals.
  • Labour Code Impact: A one-time statutory impact of ₹6.4 crore was noted in Q3FY26 due to New Labour Code changes.

References

  1. Annual Report May 2025
  2. Investor Presentation Jan 2026
  3. Earnings Call Nov 2025
  4. Annual Report May 2024

Jupiter Life Line FAQ

Jupiter Life Line today is trading in the red, down by 0.05% at ₹289.75.
Jupiter Life Line is currently trading down 0.05% on an intraday basis. In the past week the stock fell 0.84%. Stock has been down 8.23% in the past quarter and fell 1.05% in the past year. You can view this in the share price history/seasonality section.
Jupiter Life Line is listed on NSE with the ticker JLHL and on BSE as 543980. It's currently trading on NSE at a share price of ₹289.75 and on BSE with a share price of ₹291.
The market cap of Jupiter Life Line is ₹9,498.88 Cr. as of Nov 17, 2026.
Jupiter Life Line announced a INTERIM dividend of 10% which equals ₹1 in May 22, 2026.The last two ex-dates for Jupiter Life Line were Jul 04, 2025 and Aug 02, 2024. To view the full dividend history of Jupiter Life Line click here.
Jupiter Life Line has never issued bonus shares, but it has issued 1 stock split since its BSE/NSE listing. The latest announcement for Jupiter Life Line stock split was on Jul 24, 2026 at a ratio of 10:2.
Jupiter Life Line reported ₹467.04 Cr. in revenue, ₹56.17 Cr. in net profit, and ₹117.39 Cr. in EBITD as of Oct 23, 2026 for Q2 FY26-27.
According to the predictions of 6 analysts, the share price prediction for Jupiter Life Line is ₹322.17 with an upside of 11%.
The PE ratio of Jupiter Life Line is 50.95 as of Nov 17, 2026.
The PB ratio of Jupiter Life Line is 6.15 as of Nov 17, 2026.
You can view the latest analyst reports on the Jupiter Life Line reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.